With great sorrow, we announce the passing of OPHTEC's founder, Anna Margaretha Worst-van Dam. 1928 - 2020

As some countries took their first watchful steps back to normality since lockdown rules were introduced, Erik Jan Worst, OPHTEC’s president & CEO, gathered online with all country managers across the globe to discuss the new situation. “Not exactly routine calls as we know them” Erik Jan says, sitting at his desk at OPHTEC’s global headquarters in Groningen, The Netherlands.

Angle kappa is the difference between the pupillary and visual axis. This measurement is of paramount consideration in refractive surgery, as proper centration is required for optimal results. Angle kappa may contribute to MFIOL decentration and its resultant photic phenomena.¹

“My sister was extremely near-sighted, and at OPHTEC we make special lenses for that impairment. It was very satisfying that, as a brother, I was able to help her.” Somesh Kohli is Account Manager at OPHTEC, and with his years of experience he knows a lot about lenses. That knowledge stood him to good stead helping his sister: “I was right beside her when she had her surgery.”

“Patients don’t even know we exist, but our work is very important for them.” Lamija Rustempasic and her colleagues perform calculations at OPHTEC to determine the power of implantable lenses. They do this as a team: “One team member performs the calculation, another team member checks it. We want our calculations to be correct, as each calculation represents a patient.”

“As a company, you simply have to keep developing to have a future. Especially where your own speciality is concerned.” Development Leader Paolo Soleri enjoys working on new products, particularly if OPHTEC can set itself apart with these products. “Other market parties produce lenses that are placed behind the iris; we make lenses that are placed in front of the iris. Our ‘iris-fixated lens’ concept is one of our key products. Even after 35 years it still offers original solutions for the replacement of glasses and cataract surgery.”

During the 2018 ESCRS, OPHTEC has launched a new IOL concept for the correction of presbyopia with an optic using the patented Continuous Transitional Focus (CTF) technology. We are now delighted to share the findings of several surgeons spread around the globe. Find out why they are using the Precizon Presbyopic lenses.

In general, one of the most critical success factors for mIOLs is balancing your patient’s expectations. Naturally, patients compare their post-operative uncorrected visual function with their pre-operative state.

When a clinic or hospital starts using Precizon Presbyopic IOLs, a frequently asked question is: what characteristics should we consider when selecting patients for presbyopia-correcting IOLs?

Even before selecting the appropriate IOL and target refraction, the most important factor to successful cataract surgery is getting to know the patient’s personality and visual objectives: 

In the context of OPHTEC's 35th anniversary, we collected the top 3 video's of Prof. Dr Worst on YouTube.

What do these surgeons think of the new CTF Precizon™ Presbyopic IOL? We asked them two questions and this is what they answered:

Cataract surgery is perceived as a quick and relatively simple procedure. However, in case of astigmatism, the work of a multidisciplinary team and a specific surgical approach of its pre-, per- and postoperative phases is necessary for best outcomes.